Zihan Xue

3PUBLICATIONS

13CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Medical devicesPredictive and prognostic markers

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Sep 27, 2026

Isocyanate-Modified Melatplatin(IV) Enhances Antitumor Efficacy via TCF4/COL6A3-Mediated Extracellular Matrix Remodeling and cGAS-STING Pathway Activation in Bladder Cancer.

|Mar 26, 2026

Cost-Effectiveness of Circulating Tumor DNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer Based on IMvigor011 Trial.

Zihan Xue, Yunkai Qie, Shan Liang

|Dec 25, 2025

Urinary Tumor DNA to Identify Candidates for Repeat Transurethral Resection in Non-Muscle-Invasive Bladder Cancer.

Zihan Xue, Yunkai Qie, Chong Shen

Pageof 1

Frequent Collaborators

3 joint publications

Hailong Hu

2 joint publications

Zhouliang Wu

1 joint publications

Yunkai Qie

1 joint publications

Shan Liang

1 joint publications

Rongjiang Li

1 joint publications

Chong Shen

1 joint publications

Houyuan Chen

1 joint publications

Yuda Lin

1 joint publications

Peng Li

1 joint publications

Linhui Wang

Frequent Collaborators

3 joint publications

Hailong Hu

2 joint publications

Zhouliang Wu

1 joint publications

Yunkai Qie

1 joint publications

Shan Liang